InvestorsObserver
×
News Home

What is the Market's View on Anebulo Pharmaceuticals Inc (ANEB) Stock's Price and Volume Trends Thursday?

Thursday, February 01, 2024 10:48 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Anebulo Pharmaceuticals Inc (ANEB) Stock's Price and Volume Trends Thursday?

Anebulo Pharmaceuticals Inc (ANEB) stock has gained 12.50% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Anebulo Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ANEB!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ANEB Stock Today?

Anebulo Pharmaceuticals Inc (ANEB) stock is trading at $2.70 as of 9:30 AM on Thursday, Feb 1, a gain of $0.13, or 4.85% from the previous closing price of $2.58. The stock has traded between $2.63 and $2.70 so far today. Volume today is less active than usual. So far 1,762 shares have traded compared to average volume of 12,970 shares. To screen for more stocks like Anebulo Pharmaceuticals Inc click here.

More About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Click Here to get the full Stock Report for Anebulo Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App